Aislinn Macklin-Doherty
Overview
Explore the profile of Aislinn Macklin-Doherty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lau D, Fong C, Arouri F, Cortez L, Katifi H, Gonzalez-Exposito R, et al.
BMC Cancer
. 2023 Apr;
23(1):380.
PMID: 37101114
Background: Dihydropyrimidine dehydrogenase (DPD) is a key enzyme in the metabolism of fluoropyrimidines. Variations in the encoding DPYD gene are associated with severe fluoropyrimidine toxicity and up-front dose reductions are...
2.
Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment
Macklin-Doherty A, Jones M, Coulson P, Bruce C, Chau I, Alexander E, et al.
Leuk Lymphoma
. 2021 Nov;
63(3):562-572.
PMID: 34738860
Thyroid abnormalities are well reported following childhood treatment for Hodgkin Lymphoma (HL). Limited information exists for adult patients and after modern treatments. We analyzed risks of thyroid disorders in 237...
3.
Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E, et al.
JCO Glob Oncol
. 2020 Jul;
6:1046-1051.
PMID: 32639877
Purpose: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer...
4.
5.
Macklin-Doherty A
Ecancermedicalscience
. 2018 Aug;
12:ed83.
PMID: 30093918
Accountability of service delivery is becoming increasingly complex and never has this been more apparent than in the field of Oncology. Cancer care has an unrivalled level of complexity not...
6.
Yap T, Macklin-Doherty A, Popat S
Eur J Cancer
. 2016 Nov;
70:12-21.
PMID: 27866095
The majority of patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) respond to first-line EGFR tyrosine kinase inhibitors (TKIs), but nearly all inevitably acquire resistance...
7.
Wilson R, Macklin-Doherty A
Expert Rev Respir Med
. 2012 Nov;
6(5):481-92.
PMID: 23113693
Chronic obstructive pulmonary disease is a common condition which causes considerable morbidity and mortality. It is a heterogenous disorder in which the majority of patients have chronic bronchitis. Bacterial infections...